No Data
No Data
Hec cj pharm (01558) announced its interim performance. Shareholders' share of net profit was 0.685 billion yuan. "Kevin" ranked 19th among the top 50 health brands in China.
hec cj pharm (01558) announced its performance for the six months ending on June 30, 2024, during which period the group achieved...
Express News | YiChang HEC ChangJiang Pharmaceutical H1 Pretax Profit RMB 813.5 Million
Express News | YiChang HEC ChangJiang Pharmaceutical H1 Basic EPS RMB 0.78
Express News | YiChang HEC ChangJiang Pharmaceutical H1 Gross Profit RMB 1,949.2 Million
Express News | YiChang HEC ChangJiang Pharmaceutical H1 Net Income RMB 684.7 Million
HEC CJ PHARM: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
No Data